Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1957 Aug;36(8):1193–1201. doi: 10.1172/JCI103515

Exchange of Ceruloplasmin Copper With Ionic CU64 With Reference to Wilson's Disease1

I Herbert Scheinberg a, Anatol G Morell a
PMCID: PMC1072710  PMID: 13463081

Full text

PDF
1195

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ADELSTEIN S. J., COOMBS T. L., VALLEE B. L. Metalloenzymes and myocardial infarction. I. The relation between serum copper and ceruloplasmin and its catalytic activity. N Engl J Med. 1956 Jul 19;255(3):105–109. doi: 10.1056/NEJM195607192550301. [DOI] [PubMed] [Google Scholar]
  2. BEARN A. G. Genetic and biochemical aspects of Wilson's disease. Am J Med. 1953 Oct;15(4):442–449. doi: 10.1016/0002-9343(53)90134-x. [DOI] [PubMed] [Google Scholar]
  3. BEARN A. G., KUNKEL H. G. Abnormalities of copper metabolism in Wilson's disease and their relationship to the aminoaciduria. J Clin Invest. 1954 Mar;33(3):400–409. doi: 10.1172/JCI102912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BEARN A. G., KUNKEL H. G. Metabolic studies in Wilson's disease using Cu64. J Lab Clin Med. 1955 Apr;45(4):623–631. [PubMed] [Google Scholar]
  5. BICKEL H., GOLLNER I., GRUTER W., SCHULTZE H. E. Versuche zur Coeruloplasminsubstitution bei der hepatocerebralen Degeneration (Wilsonsche Krankheit). Klin Wochenschr. 1956 Sep 15;34(35-36):961–968. doi: 10.1007/BF01473248. [DOI] [PubMed] [Google Scholar]
  6. CARTWRIGHT G. E., HODGES R. E., GUBLER C. J., MAHONEY J. P., DAUM K., WINTROBE M. M., BEAN W. B. Studies on copper metabolism. XIII. Hepatolenticular degeneration. J Clin Invest. 1954 Nov;33(11):1487–1501. doi: 10.1172/JCI103027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. EARL C. J., MOULTON M. J., SELVERSTONE B. Metabolism of copper in Wilson's disease and in normal subjects; studies with Cu-64. Am J Med. 1954 Aug;17(2):205–213. doi: 10.1016/0002-9343(54)90258-2. [DOI] [PubMed] [Google Scholar]
  8. Eden A., Green H. H. Micro-determination of copper in biological material. Biochem J. 1940 Sep;34(8-9):1202–1208. doi: 10.1042/bj0341202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. FRANKLIN E. C., BAUMAN A. Liver dysfunction in hepatolenticular degeneration; a review of eleven cases. Am J Med. 1953 Oct;15(4):450–458. doi: 10.1016/0002-9343(53)90135-1. [DOI] [PubMed] [Google Scholar]
  10. GUBLER C. J. Copper metabolism in man. J Am Med Assoc. 1956 Jun 9;161(6):530–535. doi: 10.1001/jama.1956.62970060011010. [DOI] [PubMed] [Google Scholar]
  11. GUBLER C. J., LAHEY M. E., CARTWRIGHT G. E., WINTROBE M. M. Studies on copper metabolism. IX. The transportation of copper in blood. J Clin Invest. 1953 May;32(5):405–414. doi: 10.1172/JCI102752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. HOLMBERG C. G., LAURELL C. B. Oxidase reactions in human plasma caused by coeruloplasmin. Scand J Clin Lab Invest. 1951;3(2):103–107. doi: 10.3109/00365515109060581. [DOI] [PubMed] [Google Scholar]
  13. JOSELOW M., DAWSON C. R. The copper of ascorbic acid oxidase; exchange studies with radioactive copper. J Biol Chem. 1951 Jul;191(1):11–20. [PubMed] [Google Scholar]
  14. JOSELOW M., DAWSON C. R. The copper of ascorbic acid oxidase; experiments with an ion exchange resin. J Biol Chem. 1951 Jul;191(1):1–10. [PubMed] [Google Scholar]
  15. MARKOWITZ H., GUBLER C. J., MAHONEY J. P., CARTWRIGHT G. E., WINTROBE M. M. Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome. J Clin Invest. 1955 Oct;34(10):1498–1508. doi: 10.1172/JCI103201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. MATTHEWS W. B. The absorption and excretion of radiocopper in hepato-lenticular degeneration (Wilson's disease). J Neurol Neurosurg Psychiatry. 1954 Nov;17(4):242–246. doi: 10.1136/jnnp.17.4.242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mallory F. B., Parker F. Experimental Copper Poisoning. Am J Pathol. 1931 Jul;7(4):351–364.3. [PMC free article] [PubMed] [Google Scholar]
  18. Mallory F. B. The Relation of Chronic Poisoning with Copper to Hemochromatosis. Am J Pathol. 1925 Jan;1(1):117–133. [PMC free article] [PubMed] [Google Scholar]
  19. SCHEINBERG I. H., GITLIN D. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease). Science. 1952 Oct 31;116(3018):484–485. doi: 10.1126/science.116.3018.484. [DOI] [PubMed] [Google Scholar]
  20. WALSHE J. M. Penicillamine, a new oral therapy for Wilson's disease. Am J Med. 1956 Oct;21(4):487–495. doi: 10.1016/0002-9343(56)90066-3. [DOI] [PubMed] [Google Scholar]
  21. ZIMDAHL W. T., HYMAN I., COOK E. D. Metabolism of copper in hepatolenticular degeneration. Neurology. 1953 Aug;3(8):569–576. doi: 10.1212/wnl.3.8.569. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES